Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
New report takes sides in debate over COVID-19’s origins → Read More
Nine people given preventive infusions did not get infected despite deliberate exposure to parasite-carrying mosquitoes → Read More
Unexpected evidence that SARS-CoV-2 can integrate its genetic material could explain puzzling diagnostic tests in recovered COVID-19 patients → Read More
Some committee members warn against emergency use of candidates not definitively proven safe or effective → Read More
Wuhan bat virologist Shi Zhengli denies responsibility for the pandemic and calls for more international collaboration → Read More
George Gao, head of the Chinese Center for Disease Control and Prevention, offers insights from the front → Read More
The infectious disease researcher has become America’s most trusted coronavirus expert → Read More
Simple design aims to let even overwhelmed physicians and hospitals participate → Read More
Scientists are unraveling why each pathogen has its own calendar → Read More
A microbiologist overseeing testing at a major Michigan hospital system laments preventable delays → Read More
Report from joint WHO-China mission takes detailed look at results of response in hardest hit country → Read More
A pandemic seems inevitable, but its speed and impact can be mitigated → Read More
Theories abound about how the virus that’s now rampant in China made its way from bats (almost certainly) to humans → Read More
Chinese scientists are testing widely used antivirals in patients in Wuhan, the epicenter of the outbreak → Read More
Previous coronavirus outbreaks give us a strong hint. → Read More
Even in the best-case scenario, developing, testing, and mass-producing a new vaccine takes many months → Read More
Description of earliest cases suggests outbreak began elsewhere → Read More
U.S. patent officials reexamining claims about who deserves rights to enormously valuable aspect of the invention → Read More
Denis Rebrikov will use CRISPR on the same gene a China team did, but he has a different rationale → Read More
Off-target editing could complicate developing safe “base-edited” therapies → Read More